dry natural rubber / treatment of anemia in cancer / treatment of anemia associated with chronic renal failure / breast cancer treatment / preservative-free protein solution / Albumin solution / alfa / product manufacturing processes / therapeutic biologic products / treatment for hepatitis C / /
MedicalCondition
cervical cancers / available Locoregional disease / neo-adjuvant breast cancer / hemodialysis vascular access thrombosis / seizures / uncontrolled hypertension / serious allergic reactions / bone marrow fibrosis / sickle cell anemia / chronic renal failure / Early breast cancer / ischemic heart disease / skin rash / hepatitis C / Hypertensive encephalopathy / locoregional disease / severe anemia / viral diseases / metastatic breast cancer / fatigue / hematologic diseases / nonfatal myocardial infarction / non-small cell lung cancer / hypersensitivity / active malignant disease / head and neck cancer / thalassemia / advanced non-small cell lung cancer receiving / porphyria / breast cancer / INCREASED RISK OF TUMOR PROGRESSION OR RECURRENCE Chronic Renal Failure / tumor / premonitory neurologic symptoms / congestive heart failure / hemolytic anemia / thrombophlebitis / Creutzfeldt-Jakob disease / Cancer / Seizures Seizures / disease / antibody-mediated anemia / cancer receiving concomitant chemotherapy / Cervical Cancer / CJD / vascular access thrombosis / STROKE / intercurrent infections / diabetes / erythropoietin deficiency / primary squamous cell carcinoma / myocardial infarction / deep vein thrombosis / urticaria / allergic reactions / pulmonary emboli / renal failure / thrombosis / clinically evident cardiac disease / anemia / pure red cell aplasia / inflammatory / /
Aranesp® (darbepoetin alfa) For Injection WARNINGS: INCREASED MORTALITY, SERIOUS CARDIOVASCULAR EVENTS, THROMBOEMBOLIC EVENTS, STROKE and INCREASED RISK OF TUMOR PROGRESSION OR